Scarica l'app Stockscreener
97.78
0.07%
0.07
Dopo l'orario di chiusura:
97.20
-0.58
-0.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Boston Scientific Corp Borsa (BSX) Ultime notizie
What Fibonacci levels say about Boston Scientific Corporation rebound2025 Market Outlook & Proven Capital Preservation Tips - newser.com
Boston Scientific (BSX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Why Boston Scientific Corporation stock remains on watchlistsJuly 2025 News Drivers & AI Powered Market Entry Ideas - newser.com
What Makes Boston Scientific Corporation (BSX) an Investment Choice? - Yahoo Finance
Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025? - Yahoo Finance
OFI Invest Asset Management Has $1.38 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
What You Need To Know Ahead of Boston Scientific's Earnings Release - MSN
Aberdeen Group plc Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know - Yahoo Finance
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
Is Boston Scientific Corporation stock a safe buy pre earningsQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
November 28th Options Now Available For Boston Scientific (BSX) - Nasdaq
Real time alert setup for Boston Scientific Corporation performance2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
How to forecast Boston Scientific Corporation trends using time series2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Bank of America Securities Remains a Buy on Boston Scientific (BSX) - The Globe and Mail
Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings - Seeking Alpha
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Shell Asset Management Co. Increases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo
Evercore ISI Revises Boston Scientific (BSX) Price Target to $11 - GuruFocus
Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Ma - GuruFocus
Boston Scientific (BSX): Evaluating Valuation as Analyst Confidence Remains High Following Strong Segment Growth and Innovation - simplywall.st
What You Need To Know Ahead Of Boston Scientific's Earnings Release - Barchart.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Using data tools to time your Boston Scientific Corporation exitMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Cullinan Associates Inc. Sells 13,300 Shares of Boston Scientific Corporation $BSX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 5,188 Shares of Boston Scientific Corporation $BSX - MarketBeat
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $125 to $136 - 富途牛牛
QRG Capital Management Inc. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific’s Innovation Push in Endoscopy at MEDevice Boston a Sign of R&D Leadership (BSX)? - Yahoo Finance
Penobscot Investment Management Company Inc. Buys 10,177 Shares of Boston Scientific Corporation $BSX - MarketBeat
Jackson Wealth Management LLC Has $4.91 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Truist Financial Corp Sells 18,116 Shares of Boston Scientific Corporation $BSX - MarketBeat
How Are Analysts Weighing Boston Scientific’s (BSX) Innovation Pipeline Against Market Execution Strategies? - simplywall.st
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX) - Yahoo Finance
Boston Scientific stock rating reiterated at Overweight by Piper Sandler - Investing.com
FY2027 EPS Estimate for Boston Scientific Boosted by Analyst - MarketBeat
The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco - sharewise.com
Boston Scientific stock rating downgraded to Hold by Erste Group - Investing.com
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT - Insider Monkey
Consolidated Portfolio Review Corp Acquires Shares of 3,136 Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock benefits from digital adoptionEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
Top Research Reports for Boston Scientific, Union Pacific & Realty Income - Yahoo Finance
Oppenheimer Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
Leerink Partners Reaffirms Their Buy Rating on Boston Scientific (BSX) - The Globe and Mail
Truist Financial Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
27,070 Shares in Boston Scientific Corporation $BSX Bought by Lecap Asset Management Ltd. - MarketBeat
Boston Scientific aims for market leadership in electrophysiology - Yahoo Finance
Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Boston Scientific (NYSE:BSX) Price Target Raised to $129.00 at Truist Financial - Defense World
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
Oppenheimer reiterates Outperform rating on Boston Scientific stock By Investing.com - Investing.com Nigeria
Boston Scientific (BSX) Analyst Rating Update: Canaccord Genuity Raises Price Target | BSX Stock News - GuruFocus
Elutia Announces Closing Of Bioenvelope Business Sale To Boston Scientific Corporation - TradingView
What consensus target says about Boston Scientific Corporation stock2025 Biggest Moves & Verified Entry Point Detection - newser.com
Baird Raises Price Target for Boston Scientific (BSX) to $128.00 | BSX Stock News - GuruFocus
Boston Scientific stock outlook positive as TD Cowen reiterates buy rating - Investing.com
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - The Manila Times
Robert W. Baird Raises Boston Scientific (NYSE:BSX) Price Target to $128.00 - MarketBeat
Boston Scientific stock rating reiterated at Buy by Stifel on growth outlook - Investing.com
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Benzinga
0.14%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):